Top Markets
#1 TENDIES TENDIES +46.86%
#2 Cash Cat Cash Cat +33.26%
#3 Threshold Network Threshold Network +19.02%
#4 Asteroid Shiba Asteroid Shiba +17.67%
#5 OSK OSK +15.80%
#6 龙虾 (Lobster) 龙虾 (Lobster) +13.42%
#7 Ape and Pepe Ape and Pepe +12.62%
#8 Magma Finance Magma Finance +11.22%
#9 MarsCoin MarsCoin +10.44%
#10 Kite Kite +9.98%
Coin of the day
TENDIES TENDIES
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Rang in Aktien #16898
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Aktienkurs
$2.46
Marktkapitalisierung
$268.65M
Veränderung (1 Tag)
-1.73%
Veränderung (1 Jahr)
-57.06%
Land
CN
Handel VISEN Pharmaceuticals (2561)

Kategorie

Healthcare
Aktien-Split-Historie für VISEN Pharmaceuticals (2561)
Die Aktie VISEN Pharmaceuticals (Symbol: 2561) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Sep 02, 2026 statt.
Eine 2561-Aktie, die vor dem Sep 02, 2026 gekauft wurde, entspricht heute 0 2561-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 0 -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 0 -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 0 -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 5 x119
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 0 -
CH